Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 5/20 | 0.39 |
| ▸ | CA1 | P00915 | 3/20 | 0.39 |
| ▸ | USP2 | O75604 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.33 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.32 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.32 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27807939 | 0.83 | CA2 (0.63) | CA2CA1USP2TSHRMAPK1 | |
| SCHEMBL6364749 | 0.83 | CA2 (0.38) | CA2CA1USP2TSHRMAPK1 | |
| Phosphonic Acid SCHEMBL7247578 | 0.73 | ALDH1A1 (0.42) | CA2CA1USP2TSHRALDH1A1 | |
| SCHEMBL247701 | 0.73 | CA2 (0.44) | CA2CA1USP2TSHRMAPK1 | |
| SCHEMBL633191 | 0.73 | CA2 (0.44) | CA2CA1USP2TSHRMAPK1 | |
| SCHEMBL4104285 | 0.71 | SLC1A3 (0.34) | CA2CA1USP2TSHRMAPK1 | |
| SCHEMBL184812 | 0.70 | — | — | |
| SCHEMBL247061 | 0.70 | — | — | |
| SCHEMBL284647 | 0.70 | ALDH1A1 (0.50) | CA2CA1USP2TSHRALDH1A1 | |
| SCHEMBL416753 | 0.70 | CA2 (0.43) | CA2CA1USP2TSHRMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6838515-B2 | Process for the preparation of esters of (meth)acrylic acid | DSM IP ASSETS B.V. (NL) | 2005-01-04 | — | — | US | disclosed |
| US-6714712-B2 | URETHANE-FREE POLYESTER ACRYLATE OLIGOMERS HAVE ALSO BEEN USED IN RADIATION-CURABLE COATING COMPOSITIONS FOR OPTICAL GLASS FIBERS | DSM N.V. (NL) | 2004-03-30 | — | — | US | disclosed |
| EP-1385893-A2 | RADIATION CURABLE COATING COMPOSITION | DSM IP Assets B.V. (NL) | 2004-02-04 | — | — | EP | disclosed |
| EP-1353893-A1 | PROCESS FOR THE PREPARATION OF ESTERS OF (METH)ACRYLIC ACID | Dsm N.V. (NL) | 2003-10-22 | — | — | EP | disclosed |
| US-20020168164-A1 | Radiation curable coating composition | DSM IP ASSETS B.V. (NL) | 2002-11-14 | — | — | US | disclosed |
| US-20020156317-A1 | Process for the preparation of esters of (meth)acrylic acid | DSM IP ASSETS B.V. (NL) | 2002-10-24 | — | — | US | disclosed |
| WO-2002055574-A2 | RADIATION CURABLE COATING COMPOSITION | DSM NV (NL) | 2002-07-18 | — | — | WO | disclosed |
| WO-2002055473-A1 | PROCESS FOR THE PREPARATION OF ESTERS OF (METH)ACRYLIC ACID | DSM IP ASSETS B.V. (NL) | 2002-07-18 | — | — | WO | disclosed |
| EP-0644206-B1 | Olefin polymerization catalyst and process for preparing polyolefin | SHOWA DENKO KK (JP) | 1997-12-29 | — | — | EP | disclosed |
| EP-0644206-A1 | Olefin polymerization catalyst and process for preparing polyolefin | SHOWA DENKO KABUSHIKI KAISHA (JP) | 1995-03-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020156317-A1 | Process for the preparation of esters of (meth)acrylic acid | ADH1A, PAM, OXGR1 | CA2 2487/4885CA1 573/4885USP2 2341/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.